Home

Ron Bentsur, Chairman & CEO: Nuvectis Pharma NVCT Buy · Filed 24/05/13

Trade details

Type
Insider buy
Amount
$12,800
Shares · price
2,000 sh · $6.40 a share
Held after
3,244,484 sh
Trade date
24/05/10
Filed
24/05/13
Days to filing
3 days

First buy since 2023

Insiders buying this week
3 insiders
Holding change
+0.1%

Nuvectis Pharma trades, last 26 weeks

What else happened in Nuvectis Pharma around then

Filed or reported within 30 days of the trade day · 24/04/10~24/06/09

Ron Bentsur's recent trades

  • Ron Bentsur

    BuyNuvectis Pharma

    $28.6K

    Filed 25/11/06

  • Ron Bentsur

    BuyNuvectis Pharma

    $20.9K

    Filed 24/12/26

  • Ron Bentsur

    BuyNuvectis Pharma

    $98.4K

    Filed 24/11/18

  • Ron Bentsur

    BuyNuvectis Pharma

    $13.1K

    Filed 24/05/15

  • Ron Bentsur

    BuyNuvectis Pharma

    $51.5K

    Filed 24/03/19